产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量
1mg 98% 询价
- +
5mg 98% 询价
- +
10mg 98% 询价
- +
25mg 98% 询价
- +
50mg 98% 询价
- +
100mg 98% 询价
- +
晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

1173204-81-3

中文名称

PKI-402

英文名称

PKI-402

别名

BDBM50308767 | MS-30305 | STL453648 | PKI402 | CS-0565 | N-(4-(3-Ethyl-7-(4-morpholinyl)-3H-1,2,3-triazolo(4,5-d)pyrimidin-5-yl)phenyl)-N'-(4-((4-methyl-1-piperazinyl)carbonyl)phenyl)urea | 1-[4-(3-Ethyl-7-morpholin-4-yl-3H-[1,2,3]triazolo-[4,5-d]pyrimidi

标准英文名

1-(4-(3-ethyl-7-morpholino-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-yl)phenyl)-3-(4-(4-methylpiperazine-1-carbonyl)phenyl)urea

分子式

C29H34N10O3

分子量

570.66

精确分子量

570.28

SMILES

O=C(NC1=CC=C(C(N2CCN(C)CC2)=O)C=C1)NC3=CC=C(C4=NC(N5CCOCC5)=C(N=NN6CC)C6=N4)C=C3

标准SMILES

CN1CCN(CC1)C(=O)C1C=CC(=CC=1)NC(=O)NC1C=CC(=CC=1)C1=NC(=C2N=NN(CC)C2=N1)N1CCOCC1

用途

PKI-402 is a potent pan-PI3K/mTOR dual inhibitor used for targeting PI3Kα/β/γ/δ and mTOR (IC50 = 2 nM/7 nM/16 nM/14 nM and 3 nM, respectively), including PI3Kα mutants E545K and H1047R; it inhibits the growth of human tumor cell lines (IC50 = 6–349 nM); suppresses phosphorylation of PI3K and mTOR downstream effectors such as Akt (T308 and S473), p70S6K, 4EBP1, PRAS40 (T246), eNOS (S1177), and GSK3α/β (S21/S9); induces apoptosis (as indicated by cleaved PARP) in PI3Kα-mutant (E545K) and Her2-overexpressing breast cancer cells (e.g., MDA-MB-361); and demonstrates significant antitumor activity in vivo against MDA-MB-361, A549, and U87MG xenograft models.

InChIKey

ZAXFYGBKZSQBIV-UHFFFAOYSA-N

安全信息

SureRoute逆合成路线

1.  1173204-81-3 逆合成路线 1

—
—
ACJACD865
34352-59-5
ACTKCY096
1173204-81-3
来源: SureRoute

2.  1173204-81-3 逆合成路线 2

—
—
—
—
ACTKCY096
1173204-81-3
来源: SureRoute

3.  1173204-81-3 逆合成路线 3

—
—
ACJACD865
34352-59-5
ACTKCY096
1173204-81-3
来源: SureRoute
评论 0
我是晶智Agent,
您的化学小助手